Oxycodone Versus Sufentanil in Patient-controlled Intravenous Analgesia After Laparoscopic Hysterectomy
NCT ID: NCT06690307
Last Updated: 2024-12-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE4
64 participants
INTERVENTIONAL
2024-12-03
2026-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
sulfentanil group
Participants in the active comparator group will receive sulfentanil for PCIA.
patient controlled intravenous analgesia(PCIA)
Patients will receive sulfentanil for PCIA.
oxycodone group
Participants in the experimental group will receive oxycodone for PCIA.
patient controlled intravenous analgesia(PCIA)
Patients will receive oxycodone for PCIA.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
patient controlled intravenous analgesia(PCIA)
Patients will receive sulfentanil for PCIA.
patient controlled intravenous analgesia(PCIA)
Patients will receive oxycodone for PCIA.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* general anesthesia
* ASA classification I - III
* aged 18 - 65 years
Exclusion Criteria
* preoperative opioids medication
* opioids abuse
* hepatic or renal dysfunction
* cardiovascular or pulmonary dysfunction
* lack of full civil capacity or refuse to participate
18 Years
65 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Affiliated Hospital of Nantong University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Siyuan Liu
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Affiliated hospital of Nantong University
Nantong, Jiangsu, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-K115-01
Identifier Type: -
Identifier Source: org_study_id